TP53 and pancreatic neoplasm: Inactivating mutations in TP53 tumor suppressor lowers the ability of the cell to sense the DNA damage induced by gemcitabine incorporation, therefore, particularly inhibiting gemcitabine-induced apoptosis in pancreatic cancer cells[23].